US 8663681
Oral dosage forms comprising progesterone and methods of making and using the same
granted A61KA61K31/57A61K9/1623
Quick answer
US patent 8663681 (Oral dosage forms comprising progesterone and methods of making and using the same) held by TEVA WOMEN'S HEALTH, INC. expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA WOMEN'S HEALTH, INC.
- Grant date
- Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/57, A61K9/1623, A61K9/1635, A61K9/1664